Core Insights - Yonghe Medical (02279) reported a mid-term performance for the six months ending June 30, 2025, with revenue of RMB 862 million, a gross profit of RMB 550 million, representing a year-on-year increase of 3.9% [1] - The company achieved a net profit attributable to shareholders of RMB 27.913 million, marking a turnaround from a loss in the previous year, with earnings per share of RMB 0.06 [1] Company Overview - Yonghe Medical is a leading medical group in China specializing in hair medical services, offering a one-stop solution that includes hair transplantation, medical hair care, routine maintenance, and other related services [1] - The company has established a comprehensive brand matrix centered around "Yonghe Medical," which includes specialized brands such as "Yonghe Hair Transplant," "Shiyunxun" for medical hair care, "Yonghe Fazhichu" for women's aesthetic hair transplantation, and "Hafada" for medical wigs [1] Market Presence - As of June 30, 2025, the company operates 63 hair transplant medical institutions across 61 cities in China, making it the largest and most widely covered chain of hair medical services in the country [1] - The company served a total of 64,845 consumers during the six-month period ending June 30, 2025 [1]

Company Overview - Yonghe Medical Group Limited is a medical group providing one-stop hair medical services, focusing on the hair medical service market since 2005 [3] - The company has established a brand matrix including "Yonghe Medical," "Yonghe Hair Transplant," "Shiyunxun," "Yonghe Fazhichu," and "Hafada" [3] - As of June 30, 2023, the company operates 72 hair transplant medical institutions across 68 cities in China [3] - The company has built a professional medical team of over 1,600 members, including more than 300 registered doctors and over 1,000 nurses [3] Financial Performance - For the fiscal year ending December 31, 2024, Yonghe Medical reported total revenue of 1.804 billion yuan, a year-on-year increase of 1.53% [2] - The company recorded a net profit attributable to shareholders of -226 million yuan, showing a significant year-on-year increase of 58.58% [2] - The gross profit margin stands at 60.08%, while the debt-to-asset ratio is 58.65% [2] Stock Performance - Over the past month, Yonghe Medical's stock has increased by 73.45%, and year-to-date, it has risen by 117.78%, outperforming the Hang Seng Index's increase of 19.1% [2] - As of the latest trading session, the stock price was 2.22 HKD per share, reflecting a 13.27% increase with a trading volume of 3.186 million shares and a turnover of 6.9939 million HKD [1] Industry Valuation - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -2.53 times, with a median of 0.38 times [3] - Yonghe Medical's P/E ratio is -4.21 times, ranking 89th in the industry [3] - Comparatively, other companies in the sector have P/E ratios such as Giant Star Medical Holdings at 0.28 times, Jingjiu Kangliao at 0.38 times, and others ranging up to 5.35 times [3]

Group 1 - The core viewpoint of the news highlights the recent performance of Yonghe Medical, which saw a stock price increase of 9.38% on May 9, closing at 1.05 HKD per share, while the Hang Seng Index rose by 0.4% to 22867.74 points [1] - Over the past month, Yonghe Medical has experienced a cumulative increase of 1.05%, and a year-to-date increase of 6.67%, which is lower than the Hang Seng Index's increase of 13.54% [2] - Financial data shows that as of December 31, 2024, Yonghe Medical achieved total revenue of 1.804 billion RMB, a year-on-year increase of 1.53%, and a net profit attributable to shareholders of -226 million RMB, a year-on-year increase of 58.58%, with a gross margin of 60.08% and a debt-to-asset ratio of 58.65% [2] Group 2 - Currently, there are no institutional investment ratings for Yonghe Medical, and the average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -21.69 times, with a median of 0.28 times [3] - Yonghe Medical's P/E ratio stands at -2.06 times, ranking 90th in the industry, compared to other companies such as Giant Medical Holdings at 0.19 times and Jingjiu Health at 0.38 times [3] - Yonghe Medical Group Limited is a medical group providing one-stop hair medical services, focusing on the hair medical service market since 2005, and has established a brand matrix including "Yonghe Medical," "Yonghe Hair Transplant," and others, with 72 hair transplant medical institutions across 68 cities in China as of June 30, 2023 [3]